Target intelligence / Profile preview

Harmonin (USH1C)

Target
USH1C
Molecular classification
Scaffold protein, PDZ domain-containing protein
01

Overview

Harmonin is a multi-PDZ domain scaffold protein encoded by the USH1C gene, playing a critical role in the development and structural maintenance of sensory hair cells in the inner ear and photoreceptor cells in the retina (UniProt Q9Y6N9). It acts as a central hub in the Usher protein network, interacting with molecules such as cadherin-23 and myosin VIIa to organize the stereocilia bundles required for mechanotransduction (PubMed: 11239468). Mutations in the USH1C gene are the underlying cause of Usher syndrome type 1C, which manifests as profound congenital hearing loss, vestibular dysfunction, and progressive vision loss due to retinitis pigmentosa (NIH: GARD). Because harmonin is a structural scaffold rather than an enzyme, it is targeted therapeutically through genetic approaches. Current research focuses on antisense oligonucleotides (ASOs) to correct splicing errors and adeno-associated virus (AAV) vectors for gene replacement, aiming to restore functional protein levels and preserve sensory function (PubMed: 23396103, 28244866).

Other names
PDZ domain-containing protein USH1CAntigenic in intestine epitope 75AIE-75Usher syndrome type-1C proteinDFNB18
02

Mechanism of action

Splice-switching antisense oligonucleotides (ASOs) target specific pre-mRNA mutations (such as the c.216G>A founder mutation) to restore correct splicing and functional protein expression; gene therapy utilizes viral vectors to deliver a functional copy of the USH1C gene to sensory cells.

03

Biological functions

MechanotransductionProtein-protein interactionSensory perception of soundVisual perceptionCell-cell junction organization
04

Disease associations

Usher syndrome type 1CAutosomal recessive nonsyndromic deafness 18Retinitis pigmentosa
05

Safety considerations

Immune response to viral vectorsOff-target effects of antisense oligonucleotidesSurgical risks associated with subretinal or inner ear deliveryPotential for insertional mutagenesis
06

Interacting drugs

ASO-29

1 more in the full profile.

07

Biomarkers

USH1C c.216G>A mutationAudiometric thresholdsElectroretinogram (ERG) abnormalitiesVestibular function tests

Beyond the preview

Go deeper on Harmonin (USH1C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Harmonin (USH1C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call